Treatment of Anaerobic Sepsis
For anaerobic sepsis, prompt administration of intravenous antimicrobials with broad-spectrum coverage including anti-anaerobic activity within one hour of recognition is recommended, along with appropriate source control measures. 1
Initial Management
- Administer IV antimicrobials within one hour of recognition of sepsis or septic shock 1
- Obtain appropriate microbiologic cultures (including at least two sets of blood cultures with both aerobic and anaerobic bottles) before starting antimicrobials, provided this does not significantly delay therapy 1
- Perform imaging studies promptly to identify potential sources of infection requiring source control 1
Antimicrobial Therapy
Initial Empiric Therapy
- Use broad-spectrum antimicrobials covering all likely pathogens, including anaerobes 1
- For anaerobic sepsis, empiric therapy should include agents with activity against common anaerobic pathogens such as Bacteroides species (including B. fragilis group), Clostridium species, Peptostreptococcus species, and Fusobacterium species 2, 3
- Common regimens include:
Specific Antimicrobial Options for Anaerobic Coverage
- Metronidazole: 7.5 mg/kg IV every 6 hours (approximately 500 mg for a 70 kg adult) 2
- For patients with severe hepatic disease, lower doses of metronidazole should be used due to slower metabolism and potential accumulation 2
- For intra-abdominal infections, skin/soft tissue infections, gynecologic infections, and other anaerobic infections, metronidazole is particularly effective 2, 3
Source Control
- Identify specific anatomic source of infection requiring source control as rapidly as possible 1
- Implement source control measures within 12 hours of diagnosis when feasible 1
- Surgical drainage is essential in many cases of anaerobic sepsis, particularly with abscess formation 3
Duration and De-escalation
- Typical duration of therapy for anaerobic infections is 7-10 days 1, 2
- Longer courses may be necessary for:
- Reassess antimicrobial regimen daily for potential de-escalation 1
- Narrow therapy once pathogen identification and sensitivities are established and/or clinical improvement is noted 1
Special Considerations
- For multidrug-resistant anaerobic infections (rare but increasing), alternative agents such as linezolid may be considered 6
- In cases of mixed aerobic and anaerobic infections, antimicrobials appropriate for both components should be used 2, 4
- Consider the potential impact of anti-anaerobic antibiotics on gut microbiota, especially in prolonged therapy, as this may affect systemic immunity 7
- Monitor for drug interactions, particularly with warfarin, phenytoin, lithium, and disulfiram 2
Monitoring Response
- Assess clinical response daily, including vital signs, laboratory parameters (including lactate clearance), and resolution of symptoms 1
- Target mean arterial pressure of at least 65 mmHg in patients with septic shock requiring vasopressors 1
- Consider guiding resuscitation to normalize lactate in patients with elevated levels 1
Pitfalls to Avoid
- Delaying antimicrobial therapy beyond one hour from recognition of sepsis 1
- Failing to obtain appropriate cultures before starting antimicrobials 1
- Neglecting source control when indicated 1, 3
- Continuing broad-spectrum therapy unnecessarily after pathogen identification 1
- Overlooking potential drug interactions with metronidazole, particularly with alcohol, warfarin, and disulfiram 2